Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Hwang

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Haematologica|April 2, 2026
CAR-T therapy for relapsed/refractory large B-cell lymphoma in people living with HIV: efficacy, toxicity and treatment considerationsAngela Hwang, Amy A Kirkwood, Prudence Hardefeldt, et al.
Ebiomedicine|February 20, 2025
Urgent need for scaling up vaccine research on WHO priority fungal pathogens, authors' replyMateusz Hasso-Agopsowicz, Angela Hwang, Maria-Graciela Hollm-Delgado, et al.
Ebiomedicine|November 5, 2024
Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030Mateusz Hasso-Agopsowicz, Angela Hwang, Maria-Graciela Hollm-Delgado, et al.
British Journal of Haematology|June 25, 2026
CD19 chimeric antigen receptor T-cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapyAngela Hwang, Amy A Kirkwood, Maeve O'Reilly, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2026
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter StudySamantha Kurniawan, Angela Hwang, Nicole Wong Doo, et al.
Blood Advances|September 12, 2024
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapyJad Othman, Angela Hwang, Maximillian Brodermann, et al.
Bone Marrow Transplantation|August 26, 2025
A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMTSimone Cesaro, Inge Verheggen, Gloria Tridello, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Haematologica|April 2, 2026
CAR-T therapy for relapsed/refractory large B-cell lymphoma in people living with HIV: efficacy, toxicity and treatment considerationsAngela Hwang, Amy A Kirkwood, Prudence Hardefeldt, et al.
Ebiomedicine|February 20, 2025
Urgent need for scaling up vaccine research on WHO priority fungal pathogens, authors' replyMateusz Hasso-Agopsowicz, Angela Hwang, Maria-Graciela Hollm-Delgado, et al.
Ebiomedicine|November 5, 2024
Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030Mateusz Hasso-Agopsowicz, Angela Hwang, Maria-Graciela Hollm-Delgado, et al.
British Journal of Haematology|June 25, 2026
CD19 chimeric antigen receptor T-cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapyAngela Hwang, Amy A Kirkwood, Maeve O'Reilly, et al.
Asia-Pacific Journal of Clinical Oncology|March 23, 2026
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter StudySamantha Kurniawan, Angela Hwang, Nicole Wong Doo, et al.
Blood Advances|September 12, 2024
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapyJad Othman, Angela Hwang, Maximillian Brodermann, et al.
Bone Marrow Transplantation|August 26, 2025
A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMTSimone Cesaro, Inge Verheggen, Gloria Tridello, et al.
Pageof 3